133 related articles for article (PubMed ID: 9853976)
1. Comparison of total and free phenytoin serum concentrations measured by high-performance liquid chromatography and standard TDx assay: implications for the prediction of free phenytoin serum concentrations.
May TW; Rambeck B; Jürges U; Blankenhorn V; Jürgens U
Ther Drug Monit; 1998 Dec; 20(6):619-23. PubMed ID: 9853976
[TBL] [Abstract][Full Text] [Related]
2. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
Kerrick JM; Wolff DL; Graves NM
Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
[TBL] [Abstract][Full Text] [Related]
3. Derivation and evaluation of an equation for prediction of free phenytoin concentration in patients co-medicated with valproic acid.
Haidukewych D; Rodin EA; Zielinski JJ
Ther Drug Monit; 1989; 11(2):134-9. PubMed ID: 2497562
[TBL] [Abstract][Full Text] [Related]
4. Comparison of phenytoin and carbamazepine serum concentrations measured by high-performance liquid chromatography, the standard TDx assay, the enzyme multiplied immunoassay technique, and a new patient-side immunoassay cartridge system.
Rambeck B; May TW; Jürgens MU; Blankenhorn V; Jürges U; Korn-Merker E; Sälke-Kellermann A
Ther Drug Monit; 1994 Dec; 16(6):608-12. PubMed ID: 7878702
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent interaction between phenytoin and valproic acid.
Riva R; Albani F; Contin M; Perucca E; Ambrosetto G; Gobbi G; Santucci M; Procaccianti G; Baruzzi A
Neurology; 1985 Apr; 35(4):510-5. PubMed ID: 3920548
[TBL] [Abstract][Full Text] [Related]
6. Nomogram for the prediction of unbound phenytoin concentrations in patients on a combined treatment of phenytoin and valproic acid.
May TW; Rambeck B; Nothbaum N
Eur Neurol; 1991; 31(1):57-60. PubMed ID: 2015840
[TBL] [Abstract][Full Text] [Related]
7. Prediction of free levels of phenytoin and carbamazepine in patients comedicated with valproic acid.
Ratnaraj N; Hjelm M
Ther Drug Monit; 1995 Aug; 17(4):327-32. PubMed ID: 7482684
[TBL] [Abstract][Full Text] [Related]
8. Phenytoin--valproic acid interaction in rhesus monkey.
Koch KM; Ludwick BT; Levy RH
Epilepsia; 1981 Feb; 22(1):19-25. PubMed ID: 6781887
[TBL] [Abstract][Full Text] [Related]
9. Drug interactions of zonisamide with phenytoin and sodium valproate: serum concentrations and protein binding.
Tasaki K; Minami T; Ieiri I; Ohtsubo K; Hirakawa Y; Ueda K; Higuchi S
Brain Dev; 1995; 17(3):182-5. PubMed ID: 7573757
[TBL] [Abstract][Full Text] [Related]
10. Interference in immunoassay measurements of total and free phenytoin in uremic patients: a reappraisal.
Roberts WL; Rainey PM
Clin Chem; 1993 Sep; 39(9):1872-7. PubMed ID: 8375063
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
Cramer JA; Mattson RH
Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
[TBL] [Abstract][Full Text] [Related]
12. Determination of valproic acid in plasma or serum by solid-phase column extraction and gas-liquid chromatography.
Lin W; Kelly AR
Ther Drug Monit; 1985; 7(3):336-43. PubMed ID: 3931313
[TBL] [Abstract][Full Text] [Related]
13. Phenytoin free fraction determination: comparison of an improved direct serum injection high-performance liquid chromatographic method to ultrafiltration coupled with fluorescence polarization immunoassay.
Gurley BJ; Marx M; Olsen K
J Chromatogr B Biomed Appl; 1995 Aug; 670(2):358-64. PubMed ID: 8548029
[TBL] [Abstract][Full Text] [Related]
14. Valproate metabolites in high-dose valproate plus phenytoin therapy.
Sugimoto T; Muro H; Woo M; Nishida N; Murakami K
Epilepsia; 1996 Dec; 37(12):1200-3. PubMed ID: 8956852
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid-phenytoin interaction.
Friel PN; Leal KW; Wilensky AJ
Ther Drug Monit; 1979; 1(2):243-8. PubMed ID: 122160
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.
May TW; Rambeck B; Jürgens U
Ther Drug Monit; 1996 Oct; 18(5):523-31. PubMed ID: 8885114
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Simple and Rapid UPLC-MS Assay for Valproic Acid and Its Comparison With Immunoassay and HPLC Methods.
Zhao M; Li G; Qiu F; Sun Y; Xu Y; Zhao L
Ther Drug Monit; 2016 Apr; 38(2):246-52. PubMed ID: 26488205
[TBL] [Abstract][Full Text] [Related]
18. Fluctuations of unbound and total phenytoin concentrations during the day in epileptic patients on valproic acid comedication.
May T; Rambeck B
Ther Drug Monit; 1990 Mar; 12(2):124-8. PubMed ID: 2107607
[TBL] [Abstract][Full Text] [Related]
19. Validation of a free phenytoin assay on Cobas c501 analyzer using calibrators from Cobas Integra free phenytoin assay by comparing its performance with fluorescence polarization immunoassay for free phenytoin on the TDx analyzer.
Dasgupta A; Davis B; Chow L
J Clin Lab Anal; 2013 Jan; 27(1):1-4. PubMed ID: 23325740
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the factors influencing anti-epileptic drug concentrations--valproic acid.
Ieiri I; Higuchi S; Hirata K; Yamada H; Aoyama T
J Clin Pharm Ther; 1990 Oct; 15(5):351-63. PubMed ID: 2289937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
